DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Baz Ratner - 1 Tedros Adhanom Ghebreyesus - 1 Tedros - 1 Poonawalla - 1 Takeda - 1 Hanna Nohynek - 1 Gabrielle Tétrault - 1 Farber - 1
Top related locs:
Kisumu Kenya Geneva Ghana Malawi Bengaluru
Top related orgs:
Lumumba - 1 REUTERS - 1 Rights - 1 World Health Organization - 1 WHO - 1 Britain's University of Oxford - 1 UNICEF - 1 Serum Institute of India - 1

Search resuls for: "Hanna Nohynek"


2 mentions found


☆ WHO recommends malaria vaccine that will be rolled out next year
  + stars: | 2023-10-02 | by ( Gabrielle Tétrault-Farber Leroy Leo | Gabrielle Tétrault-Farber | Leroy Leo | ) www.reuters.com   time to read: +4 min
A nurse fills a syringe with malaria vaccine before administering it to an infant at the Lumumba Sub-County hospital in Kisumu, Kenya, July 1, 2022. REUTERS/Baz Ratner/File photo Acquire Licensing RightsGENEVA, Oct 2 (Reuters) - The World Health Organization (WHO) recommended on Monday the use of a second malaria vaccine to curb the life-threatening disease spread to humans by some mosquitoes. recommended the broad use of the world's first malaria vaccine called RTS,S," WHO chief Tedros Adhanom Ghebreyesus told a briefing in Geneva. "Today, it gives me great pleasure to announce that WHO is recommending a second vaccine called R21/Matrix-M to prevent malaria in children at risk of the disease." "GSK has always recognised the need for a second malaria vaccine, but it is increasingly evident that RTS,S, the first ever malaria vaccine and the first ever vaccine against a human parasite, set a strong benchmark," GSK said in a statement.
Persons: Baz Ratner, Tedros Adhanom Ghebreyesus, Tedros, Poonawalla, Takeda, Hanna Nohynek, Gabrielle Tétrault, Farber, Leroy Leo, Gareth Jones, Mark Potter Organizations: Lumumba, REUTERS, Rights, World Health Organization, WHO, Britain's University of Oxford, UNICEF, Serum Institute of India, Reuters, GSK plc, United Nations, GSK, Takeda Pharmaceuticals, Thomson Locations: Kisumu, Kenya, Geneva, Ghana, Malawi, Bengaluru
☆ WHO revises COVID-19 vaccine recommendations for Omicron-era
  + stars: | 2023-03-28 | by ( ) www.reuters.com   time to read: +3 min
[1/2] A 50 years old and immunocompromised resident receives a second booster shot of the coronavirus disease (COVID-19) vaccine in Waterford, Michigan, U.S., April 8, 2022. The health agency defined high-risk populations as older adults, as well as younger people with other significant risk factors. Meanwhile, it said healthy children and adolescents were "low priority" for COVID-19 vaccination, and urged countries to consider factors like disease burden before recommending vaccination of this group. It said the COVID-19 vaccines and boosters were safe for all ages, but the recommendations took into account other factors like cost-effectiveness. Some high-income countries like the United Kingdom and Canada are already offering those at high-risk COVID-19 boosters this spring, six months after their last dose.
0 next >>
Total: 2